iifl-logo-icon 1

Venmax Drugs & Pharmaceuticals Ltd Cash Flow Statement

15.6
(4.98%)
Dec 26, 2024|03:45:00 PM

Invest wise with Expert advice

By continuing, I accept the T&C and agree to receive communication on Whatsapp

Invest wise with Expert advice

By continuing, I accept the T&C and agree to receive communication on Whatsapp

Venmax Drugs & Pharmaceuticals Ltd FINANCIALS

Y/e 31 Mar( In .Cr)Mar-2020Mar-2019Mar-2018Mar-2017

Profit before tax

-0.26

-0.24

-0.24

-0.49

Depreciation

-0.01

0

0

0

Tax paid

0

0

0

0

Working capital

0.01

-0.14

0.01

-0.16

Other operating items

Operating

-0.27

-0.38

-0.23

-0.65

Capital expenditure

0

0.12

0

0

Free cash flow

-0.27

-0.26

-0.23

-0.65

Equity raised

-15.17

-14.7

-14.21

-10.81

Investing

0

0

0

-0.01

Financing

4.76

4.28

3.89

3.57

Dividends paid

0

0

0

0

Net in cash

-10.69

-10.68

-10.56

-7.9

Venmax Drugs & Pharmaceuticals Ltd : related Articles

No Record Found

Knowledge Center
Logo

Logo IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000

Logo IIFL Capital Services Support WhatsApp Number
+91 9892691696

Download The App Now

appapp
Loading...

Follow us on

facebooktwitterrssyoutubeinstagramlinkedintelegram

2024, IIFL Capital Services Ltd. All Rights Reserved

ATTENTION INVESTORS

RISK DISCLOSURE ON DERIVATIVES

Copyright © IIFL Capital Services Limited (Formerly known as IIFL Securities Ltd). All rights Reserved.

IIFL Securities Limited - Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248

plus
We are ISO 27001:2013 Certified.

This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.

Invest wise with Expert advice

By continuing, I accept the T&C and agree to receive communication on Whatsapp